Health TrialsbyHealthPanel

Empirical Study on Lifestyle Intervention for Elderly Hypertensive Patients in Community Based on TTM Theory

ConditionsHypertension (HTN)Age More 60yr
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-75
SponsorQu Shen

About this trial

This study intervention is based on TTM theory and implements lifestyle interventions, including nutritious diet, regular exercise, social support, sleep optimization, avoidance of addictive substances, and stress management. Through various means such as training, guidance, and motivation, motivation is formed, goals are determined, and habits are strengthened, ultimately leading to the development of a healthy lifestyle, control of blood pressure indicators, and improvement of quality of life and cognitive function. The intervention period is a total of 3 weeks, on line.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients whose blood pressure measurements taken at community hospitals meet the hypertension criteria outlined in the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision);

Aged 60-75 years old;

Have certain abilities in reading, comprehension, and communication;

Able to use a smartphone;

Disqualifiers

Exclude those with a history of severe heart, brain, kidney diseases or cancer;

Patients who currently have or have previously had mental disorders;

Patients who are currently participating in other research projects.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Lifestyle medicine

    Behavioral

    Lifestyle medicine includes Nutrition , Physical Activity , Stress Management, Restorative Sleep , Social Connectedness, Avoidance of Risky Substances .

Treatment groups

106 Participants
are divided into 2 treatment groups
Group A: Lifestyle medicineExperimental treatment 1 intervention
Group B: Routine health educationNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

blood pressure

Time frame
Baseline, the end of treatment at 3 weeks, and after 3 months
2

Patient quality of life (SF-36)

Time frame
Baseline, the end of treatment at 3 weeks, and after 3 months

Secondary outcomes

1

Patient cognitive function (AD8)

Time frame
Baseline, the end of treatment at 3 weeks, and after 3 months
2

Patients' lifestyle (HPLP Ⅱ)

Time frame
Baseline, the end of treatment at 3 weeks, and after 3 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Qu Shen

Lead sponsor

Xiamen University

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: